Dublin-based drugs maker Shire said Monday it had entered "detailed discussions" with AbbVie about a $54 billion takeover proposal. It is AbbVie's fifth takeover proposal for Shire. If the deal is successful, the combined entity would become the ninth-largest drugs company in the world. Meanwhile, other U.S. companies looking to reduce their tax bills by switching their domicile have recently failed to acquire London-listed healthcare targets. Pfizer for instance, pulled a roughly $120 billion bid for AstraZeneca in late May after the latter rejected a string of proposals. The Deal's Sarah Pringle spoke with The Deal's European Editor Laura Board about the deal.

More from Video

Dunkin' Donuts Should Just Sell Itself Already

Dunkin' Donuts Should Just Sell Itself Already

Stock Market Just Took Another Beating -- Here's What You Need to Know

Stock Market Just Took Another Beating -- Here's What You Need to Know

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Intel CEO Out After Past Relationship With Staffer - Why Stock Is Now in Play

Intel CEO Out After Past Relationship With Staffer - Why Stock Is Now in Play

Jim Cramer: Williams Sonoma Is a Digitized Play

Jim Cramer: Williams Sonoma Is a Digitized Play